![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1593140
¼¼°èÀÇ °¡Á¤¿ë Ãâ»ýÀü ¸ð´ÏÅ͸µ ±â±â ½ÃÀåHome Prenatal Monitoring Devices |
¼¼°èÀÇ °¡Á¤¿ë Ãâ»ýÀü ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2030³â±îÁö 4¾ï 4,950¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á
2023³â ¼¼°èÀÇ °¡Á¤¿ë Ãâ»ýÀü ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð´Â 3¾ï 40¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³âÀÇ CAGRÀº 5.9%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 4¾ï 4,950¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ½ÉÀå ¸ð´ÏÅÍ´Â CAGR 6.0%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 3¾ï 490¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º¯µ¿ ºÐ¼® ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 5.7%·Î ÃßÁ¤µË´Ï´Ù.
¹Ì±¹ ½ÃÀåÀº 7,900¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 5.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø
¹Ì±¹ÀÇ °¡Á¤¿ë Ãâ»ýÀü ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2023³â¿¡ 7,900¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2023-2030³âÀÇ CAGRÀ» 5.8%·Î¼ 2030³â±îÁö 7,210¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 5.5%¿Í 5.0%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼´Â µ¶ÀÏÀÌ CAGR 4.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°èÀÇ °¡Á¤¿ë Ãâ»ýÀü ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®
°¡Á¤¿ë Ãâ»ýÀü ¸ð´ÏÅ͸µ ±â±â¶õ ¹«¾ùÀ̸ç, ¾î¶»°Ô ÀÓ»êºÎ °Ç°À» Áö¿øÇϴ°¡?
°¡Á¤¿ë Ãâ»ýÀü ¸ð´ÏÅ͸µ ±â±â´Â ÀÓ»êºÎ°¡ Áý¿¡¼ Áß¿äÇÑ °Ç° ÁöÇ¥¿Í žÆÀÇ ¹ß´ÞÀ» ÃßÀûÇÒ ¼ö ÀÖµµ·Ï ÇÔÀ¸·Î½á »êÀü °ü¸®¸¦ Çõ½ÅÀûÀ¸·Î º¯È½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±â¿¡´Â žÆÀÇ ½ÉÀå ¹Úµ¿À» ¸ð´ÏÅ͸µÇÏ´Â ÅÂ¾Æ µµÇ÷¯, Ç÷¾Ð ¸ð´ÏÅÍ, Ç÷´ç ÃøÁ¤±â, ÈÞ´ë¿ë ÃÊÀ½ÆÄ ½Ã½ºÅÛ µî ´Ù¾çÇÑ ÅøÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ Àåºñ´Â °¢°¢ ƯÁ¤ ¸ñÀûÀ» °¡Áö°í ÀÖÀ¸¸ç, ÀÓ»êºÎ°¡ Á¤±âÀûÀÎ °ËÁø ¿Ü¿¡ »ê¸ð¿Í žÆÀÇ °Ç° »óŸ¦ ÀÚ¼¼È÷ »ìÆìº¼ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î ÅÂ¾Æ µµÇ÷¯´Â ÃÊÀ½ÆÄ ±â¼úÀ» ÀÌ¿ëÇØ ¾Æ±âÀÇ ½ÉÀå ¼Ò¸®¸¦ °¨ÁöÇϰí ÁõÆø½ÃÄÑ ÀÇ»çÀÇ ÁøÂû »çÀÌ»çÀÌ¿¡ ¾È½ÉÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. Ç÷¾Ð°è¿Í Ç÷´ç ÃøÁ¤±â´Â °íÇ÷¾ÐÀ̳ª Àӽżº ´ç´¢¿Í °°Àº ÇÕº´ÁõÀ» ¿¹¹æÇϱâ À§ÇØ ÀÚÁÖ ¸ð´ÏÅ͸µÇØ¾ß ÇÏ´Â °íÀ§Çè ÀÓ½ÅÀ» °ü¸®ÇÏ´Â »ç¶÷µé¿¡°Ô ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ÀÌ ±â¼úÀ» ÅëÇØ ÀÓ»êºÎ´Â ÀÚ½ÅÀÇ °Ç° »óŸ¦ ¸é¹ÐÈ÷ °üÂûÇÏ°í ¿ì·ÁµÇ´Â º¯È°¡ ÀÖÀ» °æ¿ì ½Å¼ÓÇÏ°Ô ´ëóÇÒ ¼ö ÀÖÀ¸¸ç, Á¶±â °³ÀÔÀ» À¯µµÇϰí ÇÕº´ÁõÀ» ¿¹¹æÇÒ ¼ö ÀÖ½À´Ï´Ù. ºñħ½ÀÀû ¸ð´ÏÅ͸µ ¿É¼ÇÀ» ÀÚÁÖ Á¦°øÇÔÀ¸·Î½á, °¡Á¤¿ë »êÀü Àåºñ´Â ¾È½É°ú ½Ç¿ëÀûÀÎ ÀλçÀÌÆ®À» Á¦°øÇÏ¿© ÀÓ»êºÎ °ü¸®¿¡ ´ëÇÑ º¸´Ù Àû±ØÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Áö¿øÇÏ°í º¸´Ù ¾ÈÀüÇϰí Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀӽŠ¿©Á¤À» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.
°¡Á¤¿ë »êÀü ¸ð´ÏÅ͸µ ±â±â°¡ ÀÓ»êºÎ °¡Á·µé »çÀÌ¿¡¼ Àα⸦ ²ø°í ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?
ÀӽŠÁß ÇコÄɾ ´ëÇÑ ÅëÁ¦·Â, ¾ÈÁ¤°¨, ÆíÀǼº¿¡ ´ëÇÑ ¿å±¸°¡ ³ô¾ÆÁö¸é¼ ÀÓ½ÅÀ» ¿øÇÏ´Â °¡Á·µé »çÀÌ¿¡¼ °¡Á¤¿ë »êÀü ¸ð´ÏÅ͸µ ±â±âÀÇ ÀαⰡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù ¼ö³â°£ ¿ø°ÝÀÇ·á¿Í µðÁöÅÐ °Ç°Àº ºü¸£°Ô È®ÀåµÇ¾î °³ÀÎÀÌ ÀÇ·á ¼ºñ½º¿¡ Á¢±ÙÇÏ´Â ¹æ½ÄÀ» ÀçÁ¤ÀÇÇϰí ÀÖÀ¸¸ç, »êÀü ¸ð´ÏÅ͸µ ±â±â´Â ÀÌ·¯ÇÑ Ãß¼¼ÀÇ ÀÚ¿¬½º·¯¿î ¿¬Àå¼±»ó¿¡ ÀÖ½À´Ï´Ù. °íÀ§Çè ÀÓ½ÅÀ̳ª ºÒ¾È°¨À̳ª ƯÁ¤ °Ç° ¹®Á¦°¡ µÎµå·¯Áö´Â ÀÓ½ÅÀÇ °æ¿ì, ÀÌ·¯ÇÑ ±â±â´Â ÀÓ»êºÎ°¡ ÀÚÁÖ ¹æ¹® ¿¹¾àÀ» ÇÏÁö ¾Ê°íµµ ¾Æ±âÀÇ °Ç° »óÅÂ¿Í ÀÚ½ÅÀÇ °Ç° »óŸ¦ È®ÀÎÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ±â´ÉÀº Àü¹® »êÀü Áø·á¸¦ ¹ÞÀ» ¼ö ÀÖ´Â ±âȸ°¡ Á¦ÇÑÀûÀ̰í Á¤±âÀûÀÎ Áø·á°¡ ¾î·Á¿î Áö¹æÀ̳ª ¼Ò¿ÜµÈ Áö¿ªÀÇ °¡Á·¿¡°Ô ƯÈ÷ À¯¿ëÇϸç, COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ ¿ø°ÝÀÇ·á ¿É¼ÇÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁ® ÀӽźεéÀÌ ºÒÇÊ¿äÇÑ ÀÇ·á±â°ü ¹æ¹®À» ÁÙÀ̰í Áúº´¿¡ °É¸± È®·üÀ» ³·Ãâ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.À» ÁÙÀ̰í Áúº´¿¡ °É¸± °¡´É¼ºÀ» Á¦ÇÑÇϵµ·Ï Ã˱¸Çß½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±âµéÀº ÀӽаúÁ¤À» ÅëÁ¦ÇÒ ¼ö ÀÖ´Â °¨°¢À» Á¦°øÇÏ¸é¼ º¸´Ù °³ÀÎÈµÈ Ä¡·á¸¦ Áö¿øÇÏ´Â ¿Âµð¸Çµå °Ç° ÀλçÀÌÆ®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ºÎÀÀÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅøÀÇ Ã¤Åà Áõ°¡´Â ÀÓ»êºÎ °¡Á·ÀÌ ÀӽŠ±â°£ Áß »ê¸ð¿Í žÆÀÇ ÇコÄɾ ´õ ¸¹Àº ±ÇÇÑÀ» ºÎ¿©¹Þ°í Âü¿©ÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â Àû±ØÀûÀ̰í ȯÀÚ Áß½ÉÀûÀÎ ÇコÄɾî·ÎÀÇ ±¤¹üÀ§ÇÑ º¯È¸¦ ¹Ý¿µÇÕ´Ï´Ù.
±â¼úÀÇ ¹ßÀüÀ¸·Î °¡Á¤³» »êÀü ¸ð´ÏÅ͸µÀÌ ¾î¶»°Ô °ÈµÇ°í Àִ°¡?
ÃÖ±Ù ±â¼ú ¹ßÀüÀ¸·Î °¡Á¤¿ë »êÀü ¸ð´ÏÅ͸µ ±â±âÀÇ Á¤È®¼º, »ç¿ë ÆíÀǼº ¹× Á¢±Ù¼ºÀÌ Å©°Ô Çâ»óµÇ¾î ±× ¾î´À ¶§º¸´Ù È¿°úÀûÀÌ°í »ç¿ëÀÚ Ä£ÈÀûÀ¸·Î ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ¼¾¼ ±â¼úÀÇ Çâ»ó, ¹«¼± ¿¬°á ¹× ¸ð¹ÙÀÏ ¾Û ÅëÇÕÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ ±â±â´Â ÀÌÁ¦ »ç¿ëÀÚÀÇ ½º¸¶Æ®ÆùÀ¸·Î Á÷Á¢ ½Ç½Ã°£ °Ç° µ¥ÀÌÅ͸¦ Àü´ÞÇÒ ¼ö ÀÖ°Ô µÇ¾î ¸ð´ÏÅ͸µÀÌ ¿øÈ°Çϰí À¯ÀÍÇÏ°Ô ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î °íÇØ»óµµ ÅÂ¾Æ µµÇ÷¯¿Í ÈÞ´ë¿ë ÃÊÀ½ÆÄ´Â °¨µµ¿Í Á¤È®µµ°¡ Çâ»óµÇ¾î ÀӽŠÃʱ⿡µµ žÆÀÇ ½ÉÀå ¹Úµ¿°ú ¿òÁ÷ÀÓÀ» º¸´Ù ¼±¸íÇÏ°Ô °¨ÁöÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±âµéÀº ´ëºÎºÐ ºí·çÅõ½º·Î ¿¬°áµÇ¾î ½º¸¶Æ®Æù ¿ëµµ°ú µ¿±âÈÇÏ¿© °Ç° ÁöÇ¥¸¦ ½Ã°è¿·Î ±â·ÏÇÏ¿© ÀÓ»êºÎ¿¡°Ô ÀӽŠÁß °Ç° »óÅ¿¡ ´ëÇÑ °³¿ä¸¦ Á¦°øÇÏ´Â Ãß¼¼¸¦ Ç¥½ÃÇÕ´Ï´Ù. ¿¹¸¦ µé¾î ºí·çÅõ½º ±â´ÉÀÌ ÀÖ´Â Ç÷´ç ÃøÁ¤±â³ª Ç÷¾Ð°è´Â ÃøÁ¤°ªÀ» ¸ð¹ÙÀÏ ¾Û¿¡ ÀÚµ¿À¸·Î ÀúÀåÇϰí ÀÇ·áÁø°ú °øÀ¯ÇÏ¿© ¿ø°Ý Áø·á¸¦ ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×Àº »ê¸ð¿Í žÆÀÇ °Ç° µ¥ÀÌÅÍ ÆÐÅÏÀ» ºÐ¼®ÇÏ´Â µ¥ Á¡Á¡ ´õ ¸¹ÀÌ È°¿ëµÇ°í ÀÖÀ¸¸ç, ±×·¸Áö ¾ÊÀ¸¸é ¾Ë¾ÆÂ÷¸®Áö ¸øÇÒ ¼ö ÀÖ´Â ÇÕº´ÁõÀÇ Á¶±â °æ°í ½ÅÈ£¸¦ ¹ß°ßÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀÇ À¶ÇÕÀ¸·Î °¡Á¤¿ë »êÀü ¸ð´ÏÅ͸µ ±â±â´Â ´õ ¸¹Àº »ç¶÷µéÀÌ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ÀӽŠÁß ÀÚ°¡ °ü¸®¿Í Àü¹®ÀûÀÎ ÀÇ·á ¸ð´ÏÅ͸µÀ» °ÈÇÏ´Â Á¾ÇÕÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â µ¥ÀÌÅ͸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.
°¡Á¤¿ë »êÀü ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?
°¡Á¤¿ë »êÀü ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú Çõ½Å, ÁøÈÇÏ´Â ¼ÒºñÀÚ Çൿ, ¿ø°ÝÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ °·ÂÇÑ ¼ö¿äÀÇ È¥ÇÕ¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë ÀÇ·á ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÓ»êºÎµéÀÌ Áý¿¡¼ ÀÓ»ó ¼öÁØÀÇ ¸ð´ÏÅ͸µ¿¡ Á¢±ÙÇÒ ¼ö ÀÖ°Ô µÇ¸é¼ µðÁöÅÐ °Ç° Åø¿Í °Ç° ÀλçÀÌÆ®¿¡ ´ëÇÑ ¿Âµð¸Çµå ¾×¼¼½º¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¿À´Ã³¯ÀÇ ¼ÒºñÀÚµéÀº ÀÚ½ÅÀÇ °Ç°À» º¸´Ù Àû±ØÀûÀ¸·Î °ü¸®Çϰí, ÀÚ½ÅÀÇ °Ç°À» ´õ Àß ÅëÁ¦Çϰí, ÇコÄɾ Àû±ØÀûÀ¸·Î Âü¿©ÇÒ ¼ö ÀÖ´Â ÅøÀ» ¿øÇϰí ÀÖÀ¸¸ç, COVID-19 ÆÒµ¥¹ÍÀº ÀÌ·¯ÇÑ Ãß¼¼¸¦ °¡¼ÓÈÇÏ¿© ´õ ¸¹Àº »ç¶÷µéÀÌ ´ë¸é ÀÇ·á ¼ºñ½º¸¦ Á¦ÇÑÇϰí, ½ÇÇà °¡´ÉÇÑ ´ë¾ÈÀ¸·Î ¿ø°ÝÀÇ·á ¹× ÀçÅà ¸ð´ÏÅ͸µÀ¸·Î ´«À» µ¹¸®°í ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á¿Í ÀçÅà ¸ð´ÏÅ͸µÀ¸·Î ´«À» µ¹·È½À´Ï´Ù. ¶ÇÇÑ ÀÌ ½ÃÀåÀº »ê¸ðÀÇ ³ªÀÌ, ±âÀúÁúȯ, Àӽſ¡ ´ëÇÑ ¿ì·Á¿Í °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ °íÀ§Çè ÀÓ½ÅÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀüÅëÀûÀÎ ¿¹¾à Áø·á¸¸À¸·Î´Â Á¦°øÇÒ ¼ö ¾ø´Â º¸´Ù ±ä¹ÐÇÑ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇØÁü¿¡ µû¶ó ´õ¿í °ÈµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀº ÀÇ·á ¼ºñ½º Á¢±Ù¼ºÀÌ ³·Àº Áö¿ª¿¡¼ ƯÈ÷ ´õ Å« ¿µÇâÀ» ¹ÌÄ¡¸ç, ÀçÅà ¸ð´ÏÅ͸µÀº ½Ç¿ëÀûÀ̰í È¿°úÀûÀÎ ¼Ö·ç¼ÇÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¹Ì±¹°ú °°Àº ½ÃÀå¿¡¼´Â º¸Çè ÇÁ·Î¹ÙÀÌ´õ°¡ »ê¸ð °ü¸®¸¦ À§ÇÑ µðÁöÅÐ °Ç° Åø¿¡ ´ëÇÑ º¸Çè Àû¿ëÀ» È®´ëÇϰí ÀÖÀ¸¸ç, ±ÔÁ¦Àû Áö¿øÀº ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú, ¼ÒºñÀÚ ¼ö¿ä, ±ÔÁ¦Àû Àμ¾Æ¼ºêÀÇ ¼ö·ÅÀ¸·Î °¡Á¤¿ë »êÀü ¸ð´ÏÅ͸µ ±â±â´Â Çö´ë »êÀü°ü¸®ÀÇ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸®¸Å±èÇÏ¿© ÀÓ»êºÎÀÇ °Ç°ÇÑ ÀӽŰú Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤¿¡ µµ¿òÀ» ÁÙ ¼ö ÀÖ½À´Ï´Ù.
ºÎ¹®
À¯Çü(½ÉÀå ¸ð´ÏÅÍ, ¿îµ¿ ¸ð´ÏÅÍ)
Global Home Prenatal Monitoring Devices Market to Reach US$449.5 Million by 2030
The global market for Home Prenatal Monitoring Devices estimated at US$300.4 Million in the year 2023, is expected to reach US$449.5 Million by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Heart Monitors, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$304.9 Million by the end of the analysis period. Growth in the Movement Monitors segment is estimated at 5.7% CAGR over the analysis period.
The U.S. Market is Estimated at US$79.0 Million While China is Forecast to Grow at 5.8% CAGR
The Home Prenatal Monitoring Devices market in the U.S. is estimated at US$79.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$72.1 Million by the year 2030 trailing a CAGR of 5.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.5% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.
Global Home Prenatal Monitoring Devices Market - Key Trends and Drivers Summarized
What Are Home Prenatal Monitoring Devices, and How Do They Support Maternal Health?
Home prenatal monitoring devices are transforming prenatal care by enabling expectant mothers to track important health metrics and fetal development from the convenience of their own homes. These devices include a range of tools such as fetal Dopplers, which monitor the fetal heartbeat; blood pressure monitors; glucose meters; and even portable ultrasound systems. Each of these devices serves a specific purpose, designed to give expecting parents a closer look at maternal and fetal health outside of regular medical appointments. For instance, fetal Dopplers utilize ultrasound technology to detect and amplify the baby’s heartbeat, offering peace of mind between visits to the doctor. Blood pressure monitors and glucose meters are particularly valuable for individuals managing high-risk pregnancies, where conditions like hypertension or gestational diabetes require frequent monitoring to prevent complications. This technology allows expectant mothers to keep a closer eye on their health and promptly address any concerning changes, promoting early intervention and preventing possible complications. By offering frequent, non-invasive monitoring options, home prenatal devices provide both reassurance and actionable insights, supporting a more proactive approach to maternal care and facilitating a safer, more informed pregnancy journey.
Why Are Home Prenatal Monitoring Devices Gaining Popularity Among Expecting Families?
The popularity of home prenatal monitoring devices has surged among expecting families, driven by a growing desire for control, reassurance, and convenience in managing pregnancy health. In recent years, telemedicine and digital health have expanded rapidly, redefining how individuals access healthcare, and prenatal monitoring devices are a natural extension of this trend. For high-risk pregnancies or those marked by anxiety or specific health concerns, these devices offer a way for expectant mothers to check on the baby’s well-being and their own health without the need for frequent in-person appointments. This capability is especially beneficial for families in rural or underserved regions with limited access to specialized prenatal care, where routine visits can be challenging. The onset of the COVID-19 pandemic heightened awareness of the importance of remote healthcare options, encouraging pregnant individuals to reduce non-essential healthcare visits and limit potential exposure to illness. These devices meet a growing demand for on-demand health insights that provide a sense of control over the pregnancy process while supporting more personalized care. The rising adoption of these tools reflects a broader shift toward proactive, patient-centered healthcare, allowing expecting families to feel more empowered and engaged in managing both maternal and fetal well-being throughout the pregnancy.
How Are Technological Advancements Enhancing Home Prenatal Monitoring?
Recent advancements in technology have significantly enhanced the accuracy, usability, and accessibility of home prenatal monitoring devices, making them more effective and user-friendly than ever. With improvements in sensor technology, wireless connectivity, and mobile app integration, these devices are now capable of delivering real-time health data directly to the user’s smartphone, making monitoring both seamless and informative. High-resolution fetal Dopplers and portable ultrasound devices, for example, now feature improved sensitivity and accuracy, allowing for a clearer detection of fetal heartbeat and movement, even in the early stages of pregnancy. Many of these devices connect via Bluetooth, syncing with smartphone applications that log health metrics over time and display trends that provide expectant mothers with an overview of their pregnancy health. For instance, glucose monitors and blood pressure cuffs equipped with Bluetooth capabilities automatically store readings in mobile apps, which can then be shared with healthcare providers for remote consultations. Additionally, artificial intelligence (AI) and machine learning are increasingly utilized to analyze patterns in maternal and fetal health data, helping detect early warning signs of complications that could otherwise go unnoticed. This convergence of technology has made home prenatal monitoring devices not only more accessible to a wider audience but also more capable of providing holistic, reliable data that enhances both self-care and professional medical oversight throughout pregnancy.
What Factors Are Driving the Growth of the Home Prenatal Monitoring Devices Market?
The growth of the home prenatal monitoring devices market is fueled by a mix of technological innovation, evolving consumer behaviors, and a strong demand for remote healthcare solutions. Advances in portable medical technology have made it possible for pregnant individuals to access clinical-grade monitoring at home, aligning with an increasing preference for digital health tools and on-demand access to health insights. Today’s consumers are more proactive about their healthcare, seeking tools that offer greater control over their health and allow them to participate actively in managing their well-being. The COVID-19 pandemic accelerated this trend, as more people sought to limit in-person healthcare visits and turned to telehealth and home monitoring as viable alternatives, and prenatal care has been no exception. Additionally, the market is bolstered by a rising prevalence of high-risk pregnancies due to factors like maternal age, pre-existing health conditions, and gestational concerns, which require closer monitoring than traditional appointments alone can offer. These factors are particularly relevant in regions where medical services may be less accessible, making home monitoring a practical and effective solution. Regulatory support in markets such as the United States, where insurance providers are increasingly covering digital health tools for prenatal care, is further propelling growth. This convergence of technology, consumer demand, and regulatory incentives positions home prenatal monitoring devices as essential components of modern prenatal care, supporting healthier pregnancies and more informed decision-making among expecting families.
SCOPE OF STUDY:
The report analyzes the Home Prenatal Monitoring Devices market in terms of US$ Thousand by the following Type, and Geographic Regions/Countries:
Segments:
Type (Heart Monitors, Movement Monitors)
Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.
Select Competitors (Total 51 Featured) -